Key result
Vascular extracellular matrix remodeling drives plaque instability and offers a potential therapeutic target.
Understanding vascular extracellular matrix remodeling mechanisms offers potential new therapeutic targets for managing atherosclerosis and cardiovascular diseases.
The extracellular matrix (ECM) plays a central role in the structural integrity and functionality of the cardiovascular system. Moreover, the ECM is involved in atherosclerotic plaque formation and stability. In fact, ECM remodeling affects plaque stability, cellular migration, and inflammatory responses. Collagens, fibronectin, laminin, elastin, and proteoglycans are crucial proteins during atherosclerosis development. This dynamic remodeling is driven by proteolytic enzymes such as matrix metalloproteinases (MMPs), cathepsins, and serine proteases. Exploring and investigating ECM dynamics is an important step to designing innovative therapeutic strategies targeting ECM remodeling mechanisms, thus offering significant advantages in the management of cardiovascular diseases. This review illustrates the structure and role of vascular ECM, presenting a new perspective on ECM remodeling and its potential as a therapeutic target in atherosclerosis treatments.
No takes yet. Share an insight, caveat, or question.
Nubila et al. (2024) conducted a review in Atherosclerosis. Vascular extracellular matrix remodeling, driven by proteolytic enzymes, plays a crucial role in atherosclerotic plaque formation and stability, presenting a potential therapeutic target.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: